Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors

Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors

Blocking interaction of the immune checkpoint receptor PD-1 with its ligand PD-L1 is associated with good clinical outcomes in a broad variety of malignancies. High levels of PD-L1 promote tumor growth by restraining CD8+ T-cell responses against tumors. Limiting PD-L1 expression and function is the...

Full description

Bibliographic Details
Main Authors: Eva M. Palsson-McDermott, Lydia Dyck, Zbigniew Zasłona, Deepthi Menon, Anne F. McGettrick, Kingston H. G. Mills, Luke A. O’Neill
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-10-01
Series:Frontiers in Immunology
Subjects:
PD-L1
pyruvate kinase isoform M2
LPS
macrophages
dendritic cells
tumor cells
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.01300/full

Internet

http://journal.frontiersin.org/article/10.3389/fimmu.2017.01300/full

Similar Items